No Impairment of Endothelial Function or Insulin Sensitivity with 4 Weeks of the HIV Protease Inhibitors Atazanavir or Lopinavir‐Ritonavir in Healthy Subjects without HIV Infection: A Placebo‐Controlled Trial
Open Access
- 15 August 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (4) , 567-574
- https://doi.org/10.1086/590154
Abstract
Background. Dyslipidemia alone does not fully explain the increase in cardiovascular events among patients receiving protease inhibitor (PI)-based trKeywords
This publication has 31 references indexed in Scilit:
- Improvement in HIV-related endothelial dysfunction using the anti-inflammatory agent salsalate: a pilot studyAIDS, 2008
- Severe Impairment of Endothelial Function with the HIV-1 Protease Inhibitor Indinavir is not Mediated by Insulin Resistance in Healthy SubjectsCardiovascular Toxicology, 2008
- Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- Insulin sensitivity is preserved despite disrupted endothelial functionAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Endothelial Function in HIV-Infected PersonsClinical Infectious Diseases, 2006
- Indinavir impairs endothelial function in healthy HIV-negative menAmerican Heart Journal, 2005
- HIV protease inhibitor ritonavir increases endothelial monolayer permeabilityBiochemical and Biophysical Research Communications, 2005
- HIV protease inhibitor ritonavir decreases endothelium-dependent vasorelaxation and increases superoxide in porcine arteriesCardiovascular Research, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997